Boston Scientific Corporation

NYSE:BSX 株式レポート

時価総額:US$133.3b

Boston Scientific マネジメント

マネジメント 基準チェック /34

Boston Scientificの CEO はMike Mahoneyで、 Oct2011年に任命され、 の在任期間は 13.08年です。 の年間総報酬は$ 18.72Mで、 7.5%給与と92.5%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.12%を直接所有しており、その価値は$ 156.52M 。経営陣と取締役会の平均在任期間はそれぞれ8.6年と8.3年です。

主要情報

Mike Mahoney

最高経営責任者

US$18.7m

報酬総額

CEO給与比率7.5%
CEO在任期間13.1yrs
CEOの所有権0.1%
経営陣の平均在職期間8.6yrs
取締役会の平均在任期間8.3yrs

経営陣の近況

Recent updates

Why The Fundamentals Make Me Bullish On Boston Scientific

Oct 31

Boston Scientific Q3: Good Growth, But Not Good Enough To Justify Its P/E Ratio

Oct 23

Is Boston Scientific (NYSE:BSX) A Risky Investment?

Oct 10
Is Boston Scientific (NYSE:BSX) A Risky Investment?

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement

Sep 24
Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement

Boston Scientific: Forward Returns Are Likely To Be Disappointing For Investors

Sep 20

Boston Scientific Corporation's (NYSE:BSX) P/E Still Appears To Be Reasonable

Sep 09
Boston Scientific Corporation's (NYSE:BSX) P/E Still Appears To Be Reasonable

A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Aug 23
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

The Strong Earnings Posted By Boston Scientific (NYSE:BSX) Are A Good Indication Of The Strength Of The Business

Aug 08
The Strong Earnings Posted By Boston Scientific (NYSE:BSX) Are A Good Indication Of The Strength Of The Business

Boston Scientific Q2 Earnings Preview: Can The Rally Continue?

Jul 17

Here's Why We Think Boston Scientific (NYSE:BSX) Is Well Worth Watching

Jul 05
Here's Why We Think Boston Scientific (NYSE:BSX) Is Well Worth Watching

Should You Investigate Boston Scientific Corporation (NYSE:BSX) At US$77.00?

Jun 21
Should You Investigate Boston Scientific Corporation (NYSE:BSX) At US$77.00?

Boston Scientific Has Become A Standout Growth Story In Med-Tech

Jun 13

Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price

Jun 08
Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price

Is Boston Scientific (NYSE:BSX) Using Too Much Debt?

May 10
Is Boston Scientific (NYSE:BSX) Using Too Much Debt?

Boston Scientific (NYSE:BSX) Is Reinvesting At Lower Rates Of Return

Apr 22
Boston Scientific (NYSE:BSX) Is Reinvesting At Lower Rates Of Return

Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash

Apr 05

A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Mar 26
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease

Feb 29
We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease

What You Can Learn From Boston Scientific Corporation's (NYSE:BSX) P/E

Feb 15
What You Can Learn From Boston Scientific Corporation's (NYSE:BSX) P/E

Is Boston Scientific (NYSE:BSX) A Risky Investment?

Feb 02
Is Boston Scientific (NYSE:BSX) A Risky Investment?

Boston Scientific (NYSE:BSX) Could Be Struggling To Allocate Capital

Jan 19
Boston Scientific (NYSE:BSX) Could Be Struggling To Allocate Capital

Boston Scientific: Portfolio Updates Driving Top-Line Growth

Jan 17

Boston Scientific: Continued M&A Drives More Growth

Jan 10

Is Boston Scientific Corporation (NYSE:BSX) Worth US$56.1 Based On Its Intrinsic Value?

Dec 04
Is Boston Scientific Corporation (NYSE:BSX) Worth US$56.1 Based On Its Intrinsic Value?

Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet?

Nov 03
Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet?

Boston Scientific: Delivering Strong Growth, But Sector Derating Is A Big Issue

Oct 30

ADVENT Offers Up An Early Present For Boston Scientific Investors

Aug 28

Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Aug 24
Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)

Boston Scientific (NYSE:BSX) Seems To Use Debt Quite Sensibly

Jul 25
Boston Scientific (NYSE:BSX) Seems To Use Debt Quite Sensibly

Boston Scientific Remains Operationally Sound But May Have Limited Upside

Jul 14

Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital

Jul 10
Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital

CEO報酬分析

Boston Scientific の収益と比較して、Mike Mahoney の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

US$2b

Jun 30 2024n/an/a

US$2b

Mar 31 2024n/an/a

US$2b

Dec 31 2023US$19mUS$1m

US$2b

Sep 30 2023n/an/a

US$1b

Jun 30 2023n/an/a

US$861m

Mar 31 2023n/an/a

US$846m

Dec 31 2022US$17mUS$1m

US$642m

Sep 30 2022n/an/a

US$596m

Jun 30 2022n/an/a

US$828m

Mar 31 2022n/an/a

US$754m

Dec 31 2021US$16mUS$1m

US$985m

Sep 30 2021n/an/a

US$1b

Jun 30 2021n/an/a

US$526m

Mar 31 2021n/an/a

US$201m

Dec 31 2020US$14mUS$667k

-US$115m

Sep 30 2020n/an/a

US$4b

Jun 30 2020n/an/a

US$4b

Mar 31 2020n/an/a

US$4b

Dec 31 2019US$16mUS$1m

US$5b

Sep 30 2019n/an/a

US$1b

Jun 30 2019n/an/a

US$1b

Mar 31 2019n/an/a

US$2b

Dec 31 2018US$14mUS$1m

US$2b

Sep 30 2018n/an/a

US$670m

Jun 30 2018n/an/a

US$521m

Mar 31 2018n/an/a

US$112m

Dec 31 2017US$13mUS$1m

US$104m

報酬と市場: Mikeの 総報酬 ($USD 18.72M ) は、 US市場 ($USD 12.74M ) の同規模の企業の平均を上回っています。

報酬と収益: Mikeの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Mike Mahoney (59 yo)

13.1yrs

在職期間

US$18,723,735

報酬

Mr. Michael F. Mahoney, also known as Mike, has been Independent Director of CVS Health Corporation since November 01, 2023. He has been Chairman of Boston Scientific Corporation since May 3, 2016, and is...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Michael Mahoney
Chairman13.1yrsUS$18.72m0.12%
$ 156.5m
Daniel Brennan
Executive VP & CFO10.8yrsUS$5.83m0.015%
$ 20.2m
Joseph Fitzgerald
Executive VP & Group President of Cardiology14.8yrsUS$5.59m0.011%
$ 15.0m
Jeffrey Mirviss
Executive VP & President of Peripheral Interventions11.8yrsUS$3.78m0.0019%
$ 2.5m
Arthur Crosswell Butcher
Executive VP and Group President of MedSurg & Asia Pacific8.3yrsUS$4.27m0.0016%
$ 2.2m
John Sorenson
Executive Vice President of Global Operations2.5yrsデータなし0.0025%
$ 3.4m
Emily Woodworth
Senior VPless than a yearデータなし0.00026%
$ 346.6k
Jodi Eddy
Senior VP and Chief Information & Digital Officer8.9yrsデータなしデータなし
Jonathan Monson
Senior VP of Investor Relationsless than a yearデータなし0.0026%
$ 3.4m
Vance Brown
Senior VP3.4yrsデータなし0.0023%
$ 3.1m
Mary Moynihan
Senior VP of Market Access & Chief Marketing Officer3.5yrsデータなしデータなし
Wendy Carruthers
Executive Vice President of Human Resources11.9yrsデータなし0.0022%
$ 2.9m

8.6yrs

平均在職期間

56yo

平均年齢

経験豊富な経営陣: BSXの経営陣は経験豊富で経験豊富です(平均在職期間は8.6年)。


取締役

名称ポジション在職期間報酬所有権
Michael Mahoney
Chairman12yrsUS$18.72m0.12%
$ 156.5m
Edward Ludwig
Lead Independent Director10.7yrsUS$360.00k0.0030%
$ 4.0m
Ellen Zane
Independent Director8.6yrsUS$335.00k0.0033%
$ 4.4m
Yoshiaki Fujimori
Independent Director8.3yrsUS$320.00k0.00020%
$ 266.6k
David Wichmann
Independent Director3.4yrsUS$338.75k0.0027%
$ 3.6m
Cheryl Pegus
Directorless than a yearデータなしデータなし
David Habiger
Directorless than a yearデータなし0.00024%
$ 319.9k
Charles Dockendorff
Independent Director9.6yrsUS$326.25k0.0043%
$ 5.7m
John Sununu
Independent Director15.6yrsUS$340.00k0.0036%
$ 4.8m
Jessica Mega
Independent Director1.4yrsUS$233.23k0.00042%
$ 559.9k
Susan Morano
Independent Director1.4yrsUS$233.23k0.00027%
$ 359.9k

8.3yrs

平均在職期間

60.5yo

平均年齢

経験豊富なボード: BSXの 取締役会経験豊富 であると考えられます ( 8.3年の平均在任期間)。